NewsThe rise and fall of treatment trials in group 3 pulmonary hypertension: Where do we go from here?Author:Christopher King, MD, FCCPPublish date: December 6, 2017Treatment of fibrotic interstitial lung disease (ILD) is often dissatisfying to clinicians and patients. Despite significant advances in the field,...Read More
